Nomad Power Solutions Inc. (NMAD) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-02, Nomad Power Solutions Inc. (NASDAQ: NMAD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $3.56 (+0.56% 1D, market cap $57.0M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NMAD ranks #751 in composite RQD confidence.
Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), NMAD carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, HYFT (MindWalk Holdings Corp.) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $57.1M) and BOLD (Boundless Bio Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -35.0%, cap $57.3M). Among the 5-stock peer group, NMAD leads on earnings multiple (N/A) while NMAD leads on capital efficiency (-35.0% ROIC).
Per NMAD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001335105), Nomad Power Solutions Inc. generated $0 in revenue, -$6.1M in net income, and -$3.1M in free cash flow against $12.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 52% Gross Margin
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
While NMAD currently carries a cautious 33/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.88) and Max Pain ($3.74) forces dealer call-delta covering toward $8.80.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Nomad Power Solutions Inc. (NMAD) advanced +0.56% to $3.56, trading at 20% of its 52-week range ($2.36 – $8.38). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
Utility Specialists and Elgin B. Robertson extend coverage across Southeast and South Central U.S. through performance-based sales relationships BOCA RATON, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions,
Backlog orders reflect growing demand for transportable, utility-grade battery storage solutions across multiple end markets BOCA RATON, Fla., Oct. 15, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. (Nasdaq: NMAD)
NOMAD Power Solutions, Inc. (Nasdaq: NMAD) ("NOMAD" or the "Company"), a provider of transportable, utility-grade battery energy storage systems ("BESS") through its wholly owned subsidiary NOMAD
Voyager and Voyager Falcon Systems Showcase Rapidly Deployable, Utility-Grade Battery Power at 26 Stops Across Three Regional Roadshows in October and November BOCA RATON, Fla., Oct. 06, 2026 (GLOBE NEWSWIRE) -- NOMAD Po
BOCA RATON, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company") (Nasdaq: NMAD) (formerly LIXTE Biotechnology Holdings), a provider of transportable, utility-grade battery energy
GEL brings established relationships across Canada’s mining, utility and industrial sectors BOCA RATON, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company") (Nasdaq: NMAD) (form
Filing highlights commercial deployments, strengthened capital position and growing opportunity for rapidly deployable power infrastructure BOCA RATON, Fla, Sept. 17, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions (Nasda
There is a quiet argument running underneath the current industrial buildout about who should own the equipment. On one side sits the traditional answer: a project needs an asset, so the project buys the asset, installs
Certified Traveler system supports resilient power deployment for Missanabie Cree First Nation in Northern Ontario, Canada BOCA RATON, Fla., Aug. 19, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions Inc. ("NOMAD" or the "C
Among Recent Developments: -Corporate Name Change- -Acquisition of Leading AI Energy Infrastructure Equipment/Services Provider- -Addition to Board of Renowned Energy Sector Executive- -Key Leadership Appointments at Ope
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on NMAD today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for NMAD. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, Nomad Power Solutions Inc. (NMAD) ranks #751 by composite RQD confidence (33/100, grade E) and #730 by equity capitalization ($57.0M). Within this direct 5-issuer industry benchmark cohort, NMAD leads on earnings valuation at N/A trailing P/E, while NMAD leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. HYFT currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with NMAD at 33/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| NMAD
ACTIVE
Nomad Power Solutions Inc. | E | 33/100 | — | — | -35.0% | +0.56% | $57.0M | Benchmark Subject |
| HYFT MindWalk Holdings Corp. | D+ | 58/100 | — | — | — | -5.83% | $57.1M | /hyft-vs-nmad → |
| BOLD Boundless Bio Inc. | D- | 41/100 | — | — | -35.0% | -0.40% | $57.3M | /bold-vs-nmad → |
| ONCY Oncolytics Biotech Inc. | D | 45/100 | — | — | -35.0% | -0.54% | $56.1M | /oncy-vs-nmad → |
| HRTX Heron Therapeutics Inc. | D- | 37/100 | — | 73.3% | -35.0% | -5.67% | $55.9M | /hrtx-vs-nmad → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Nomad Power Solutions Inc. (NMAD) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$6.1M, operating cash flow of -$3.1M, and free cash flow of -$3.1M (+3.0% YoY). On the balance sheet, NMAD closed FY2025 with $12.7M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $0 | -$6.1M | -$3.1M | -$3.1M | $12.7M | — |
| FY2024 (FY) | 2024-12-31 | $0 | -$3.6M | -$3.2M | -$3.2M | $1.1M | — |
| FY2023 (FY) | 2023-12-31 | $0 | -$5.1M | -$4.3M | -$4.3M | — | — |
As of 2026-11-02, Nomad Power Solutions Inc. (NASDAQ: NMAD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $3.56 (+0.56% 1D, market cap $57.0M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, NMAD ranks #751 in composite RQD confidence.
Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), NMAD carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, HYFT (MindWalk Holdings Corp.) holds a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $57.1M) and BOLD (Boundless Bio Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -35.0%, cap $57.3M). Among the 5-stock peer group, NMAD leads on earnings multiple (N/A) while NMAD leads on capital efficiency (-35.0% ROIC).
Per NMAD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001335105), Nomad Power Solutions Inc. generated $0 in revenue, -$6.1M in net income, and -$3.1M in free cash flow against $12.7M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
NMAD last traded at $3.56 (+0.56% on volume of 584,416 shares), positioning the stock -8.25% below its 50-day simple moving average ($3.88) and -16.43% below its 200-day simple moving average ($4.26). Across its 52-week range of $2.36 to $8.38, NMAD sits at the 19.9% percentile with a 14-day RSI of 42.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($3.11 to $4.01).
Why NMAD Stock advanced +0.56% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
Per the Roarable RQD 5-pillar rating engine, Nomad Power Solutions Inc. (NMAD) carries a composite score of 33/100 (E — Roarable Strong Sell — Forensic Risk / Avoid) at a current price of $3.56 (+0.56%). Fundamental cash generation scores 8/20 (ROIC -35.0%, FCF yield -5.39%), institutional 13F whale accumulation scores 4/20, insider conviction scores 3/20, macro regime alignment scores 8/20 (Beta 1.00), and forensic balance-sheet protection scores 10/20 (Altman Z-Score N/A, Piotroski F-Score 2/9).
Investor Implication: At current trailing P/E and current forward P/E within Biotechnology: Pharmaceutical Preparations, upside depends on sustained operating margin expansion (—) and free cash flow conversion relative to the 52-week range of $2.36 – $8.38.
Operating in Biotechnology: Pharmaceutical Preparations (Health Care), NMAD is sensitive to 2nd-order capital expenditure cycles, input cost spreads (gross margin —), and institutional positioning across its peer cohort. Prospective investors should monitor quarterly order backlog conversion, sector capex guidance, and Form 4 insider cluster activity (0 recent filings tracked).
Open Questions to Watch: (1) Margin trajectory vs. peer median; (2) FCF conversion sustainability over the next 4 quarters; (3) Institutional 13F rebalancing around upcoming earnings.
Real-time company headlines, analyst actions, and sector developments for Nomad Power Solutions Inc. (NMAD) • Click "Debate This Headline" to argue it in the Roar Pit below
Utility Specialists and Elgin B. Robertson extend coverage across Southeast and South Central U.S. through performance-based sales relationships BOCA RATON, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions,
Backlog orders reflect growing demand for transportable, utility-grade battery storage solutions across multiple end markets BOCA RATON, Fla., Oct. 15, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. (Nasdaq: NMAD)
NOMAD Power Solutions, Inc. (Nasdaq: NMAD) ("NOMAD" or the "Company"), a provider of transportable, utility-grade battery energy storage systems ("BESS") through its wholly owned subsidiary NOMAD
Voyager and Voyager Falcon Systems Showcase Rapidly Deployable, Utility-Grade Battery Power at 26 Stops Across Three Regional Roadshows in October and November BOCA RATON, Fla., Oct. 06, 2026 (GLOBE NEWSWIRE) -- NOMAD Po
BOCA RATON, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company") (Nasdaq: NMAD) (formerly LIXTE Biotechnology Holdings), a provider of transportable, utility-grade battery energy
GEL brings established relationships across Canada’s mining, utility and industrial sectors BOCA RATON, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions, Inc. ("NOMAD" or the "Company") (Nasdaq: NMAD) (form
Filing highlights commercial deployments, strengthened capital position and growing opportunity for rapidly deployable power infrastructure BOCA RATON, Fla, Sept. 17, 2026 (GLOBE NEWSWIRE) -- NOMAD Power Solutions (Nasda
There is a quiet argument running underneath the current industrial buildout about who should own the equipment. On one side sits the traditional answer: a project needs an asset, so the project buys the asset, installs
Welcome to the NMAD (Nomad Power Solutions Inc.) Roar Pit. Current RQD Composite is 33/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Biotechnology: Pharmaceutical Preparations. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Everyone in here is repeating the bull case on NMAD, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Nomad Power Solutions Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
Looking at the 5-pillar RQD breakdown on NMAD, the market is fixating on short-term headline noise in Biotechnology: Pharmaceutical Preparations and ignoring the balance sheet and cash flow trajectory. At $3.56 (52-wk range $2.36 - $8.38), any beat on forward guidance forces shorts and underweight funds to chase.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).